Published in J Paediatr Child Health on June 03, 2014
Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology (2007) 2.96
Probiotics: sorting the evidence from the myths. Med J Aust (2008) 2.21
Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol (2008) 2.06
Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol (2007) 1.88
Eosinophilic esophagitis in children with celiac disease. J Gastroenterol Hepatol (2007) 1.74
Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis (2010) 1.69
Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease. Inflamm Bowel Dis (2010) 1.42
Development and assessment of a modified Pediatric Crohn Disease Activity Index. J Pediatr Gastroenterol Nutr (2010) 1.40
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology (2010) 1.32
Defensins and inflammation: the role of defensins in inflammatory bowel disease. J Gastroenterol Hepatol (2009) 1.24
Isolation and detection of Campylobacter concisus from saliva of healthy individuals and patients with inflammatory bowel disease. J Clin Microbiol (2010) 1.20
Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis (2009) 1.18
Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci (2011) 1.18
Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol (2006) 1.16
Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2008) 1.14
Update of fecal markers of inflammation in inflammatory bowel disease. J Gastroenterol Hepatol (2011) 1.13
A review of activity indices and end points for clinical trials in children with Crohn's disease. Inflamm Bowel Dis (2005) 1.13
Microbial dysbiosis in pediatric patients with Crohn's disease. J Clin Microbiol (2012) 1.10
Crohn's and colitis in children and adolescents. World J Gastroenterol (2012) 1.10
Comment to: Changes of faecal microflora in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis (2012) 1.09
Factors that determine risk for surgery in pediatric patients with Crohn's disease. Clin Gastroenterol Hepatol (2010) 1.00
The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLoS One (2011) 1.00
The prevalence and polymorphisms of zonula occluden toxin gene in multiple Campylobacter concisus strains isolated from saliva of patients with inflammatory bowel disease and controls. PLoS One (2013) 1.00
Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed Res Int (2013) 1.00
An update of the role of nutritional therapy in the management of Crohn's disease. J Gastroenterol (2012) 0.99
Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease. Inflamm Bowel Dis (2015) 0.99
Esophageal subepithelial fibrosis and hyalinization are features of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2011) 0.95
Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease. Inflamm Bowel Dis (2008) 0.94
Assessing disease activity in ulcerative colitis: patients or their physicians? Inflamm Bowel Dis (2010) 0.94
Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2009) 0.93
C-reactive protein and disease activity in children with Crohn's disease. Dig Dis Sci (2010) 0.91
Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis. PLoS One (2010) 0.91
Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study. Clin Gastroenterol Hepatol (2008) 0.90
Congenital short bowel syndrome: a case report and review of the literature. Can J Gastroenterol (2008) 0.89
Experiences and barriers to Health-Related Quality of Life following liver transplantation: a qualitative analysis of the perspectives of pediatric patients and their parents. Health Qual Life Outcomes (2010) 0.87
Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2014) 0.87
Understanding quality of life for children after liver transplantation: a work in progress. Liver Transpl (2008) 0.86
Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr (2010) 0.86
Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease. J Gastroenterol Hepatol (2010) 0.86
Detection of Helicobacteraceae in intestinal biopsies of children with Crohn's disease. Helicobacter (2010) 0.86
Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation. Dig Dis Sci (2013) 0.85
Exclusive enteral nutrition in the management of perianal Crohn's disease in children. J Dig Dis (2010) 0.84
Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis. J Crohns Colitis (2013) 0.84
Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2015) 0.84
Exclusive enteral nutrition for children with Crohn's disease: use in Australia and attitudes of Australian paediatric gastroenterologists. J Paediatr Child Health (2009) 0.84
Do parents and children agree? Quality-of-life assessment of children with inflammatory bowel disease and their parents. J Pediatr Gastroenterol Nutr (2014) 0.82
Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model. J Gastroenterol (2011) 0.82
Complementary and alternative medicine in children attending gastroenterology clinics: usage patterns and reasons for use. J Paediatr Child Health (2011) 0.81
Assessment of nutritional status and serum leptin in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2011) 0.80
Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition. Inflamm Bowel Dis (2011) 0.79
Budesonide for Crohn's disease. Expert Opin Drug Metab Toxicol (2009) 0.79
Campylobacter concisus and exotoxin 9 levels in paediatric patients with Crohn's disease and their association with the intestinal microbiota. J Med Microbiol (2013) 0.78
Dietary intakes of children with Crohn's disease. Br J Nutr (2009) 0.78
Mathematical weighting of a clinimetric index (Pediatric Ulcerative Colitis Activity Index) was superior to the judgmental approach. J Clin Epidemiol (2009) 0.78
Single High-Dose Oral Vitamin D3 Therapy (Stoss): A Solution to Vitamin D Deficiency in Children With Inflammatory Bowel Disease? J Pediatr Gastroenterol Nutr (2015) 0.77
Family adjustment and parenting stress when an infant has serious liver disease: the Australian experience. J Pediatr Gastroenterol Nutr (2015) 0.77
Low rate of inflammatory bowel disease in the Australian indigenous paediatric population. J Paediatr Child Health (2014) 0.77
Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease. Inflamm Bowel Dis (2014) 0.77
Thiopurine-induced pancreatitis in inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol (2014) 0.77
Campylobacter concisus: a new character in the Crohn's disease story? J Clin Microbiol (2009) 0.76
Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: A workshop to identify barriers and enablers. Can J Gastroenterol Hepatol (2015) 0.76
Early Changes in Microbial Community Structure Are Associated with Sustained Remission After Nutritional Treatment of Pediatric Crohn's Disease. Inflamm Bowel Dis (2016) 0.76
Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver disease. J Pediatr Gastroenterol Nutr (2014) 0.76
The Gut Microbiome of Pediatric Crohn's Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response. Inflamm Bowel Dis (2016) 0.76
The complement system in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.75
Subclinical intestinal inflammation in siblings of children with Crohn's disease. Dig Dis Sci (2010) 0.75
Neutrophil transintestinal epithelial migration to CXCR2 ligands is regulated by adenosine. J Pediatr Gastroenterol Nutr (2012) 0.75
The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis. Genes Nutr (2015) 0.75
Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease? J Pediatr Gastroenterol Nutr (2013) 0.75
Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease. Can J Gastroenterol Hepatol (2014) 0.75
Markers of inflammation in the breath in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2014) 0.75
Use of LARA-urea breath test in the diagnosis of Helicobacter pylori infection in children and adolescents: a preliminary study. Can J Gastroenterol (2003) 0.75
Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study. Am J Gastroenterol (2017) 0.75
Family Impact and Infant Emotional Outcomes Following Diagnosis of Serious Liver Disease or Transplantation in Infancy. J Pediatr Gastroenterol Nutr (2016) 0.75
A case of duodenal web occurring in Prader-Willi syndrome. J Paediatr Child Health (2005) 0.75
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. Cell Host Microbe (2017) 0.75